Integrative Cancer Therapy for Breast Cancer Improving Quality of Life and Survival Time for Patients With around 74,500 new cases annually, breast cancer is by far the most common cancer in women, according to the Center for Cancer Registry Data of the Robert Koch Institute. According to that, one in eight women will develop breast cancer in the course of her life, and one in six affected women is not yet 50 years old. Nothing is known about the actual cause of the disease, but risk factors are

Integrative Medicine Using the Examples of: The Hospital for Naturopathy, Munich And LIMed SUMMARY The most important principle of integrative medicine is the combination of conventional medicine and complementary medicine into a meaningful overall concept. The goal is to find the best individual therapy for the patients and to reduce side effects as much as possible. The decisive factor here is also explicitly the patients, who should be enabled to actively and responsibly participate in decision-making about an overall medical concept for their treatment. This article presents two

Current Status of Long-Covid Abstract At the beginning of the COVID-19 pandemic, the acute infection was the focus of interest, but since then the perspective has changed. After the infection, impairments may persist in those affected, at both the physical as well as the mental level – the so-called “Long-Covid Syndrome” or “Post-Covid Syndrome”. The healthcare system is doing research on causes and treatment options. In practice it has been shown that previously well-established naturopathic procedures make a positive contribution to the therapy of patients with Long-Covid. Especially

Interim Results of the Ongoing Long-/Post-Covid Study From the Hospital for Naturopathic Medicine in Munich. Abstract In December 2021, we started an in-house observational study at the Krankenhaus für Naturheilweisen (Clinic for Internal Medicine, Naturopathy and Homeopathy) on the topic of “Effectiveness of our Naturopathic Complex Treatment for Long-/Post-Covid Syndrome”. While the first, initially small numbers of patients with Long-/Post-Covid came to us in the second half of 2020, these patients developed into one of our largest patient groups during 2021, in some cases with long-lasting and/or severe